Tang KT, Hsieh CW, Chen HH, Chen YM, et al. The effectiveness of tocilizumab in treating refractory adult-onset Still's disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response. Clin Rheumatol 2022;41:557-566.
PMID: 34535869